-
Real-World Evidence of Setmelanotide in Patients with Rare Melanocortin-4 Receptor Pathway Diseases: Baseline Findings from the RESTORE Longitudinal Survey Study
Mar 10, 2025, 14:00 PM -
Challenges for PAIC in Rare Diseases: Results of a Systematic Literature Review
Mar 10, 2025, 14:00 PM -
An Overview of the Patient Journey and Treatment Utilization in Patients With Prurigo Nodularis
Mar 10, 2025, 14:00 PM -
Efficiency Benefits and Practice Value of Alcon's Digital Cataract Surgery Planning System
Mar 10, 2025, 14:00 PM -
A Targeted Literature Review of Patient Perspectives of Placebo Use in Clinical Trials: How Can the Patient Voice Help Drug Developers in Trial Design, Recruitment, and Retention?
Mar 10, 2025, 14:00 PM -
Mapping Health-Related Quality of Life (HRQoL) Measures to Preference Based Measures in Metastatic Hormone Sensitive Prostate Cancer (mHSPC): A systematic literature review
Mar 10, 2025, 14:00 PM -
The Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A cross-Sectional Examination of Emergency Department Visits and Inpatient Stays in US claims
Mar 10, 2025, 14:00 PM -
Characterizing Social Determinants of Health in the Population Receiving Respiratory Syncytial Virus Vaccination in a Nationwide Pharmacy Chain in the United States
Mar 10, 2025, 14:00 PM -
From Data to Decisions: The Role of Real-World Evidence in Recent Multiple Myeloma Drug Approvals in the US and EU
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Costs in Patients with Itch-Dominant Moderate-to-Severe Atopic Dermatitis Treated in Private Dermatology Facilities in the United States
Mar 10, 2025, 14:00 PM -
Leveraging Consumer-Grade Wearables in Clinical Trials: Insights From Digital Primary Endpoints
Mar 10, 2025, 14:00 PM -
Healthcare Resource U tilization and Healthcare Costs After Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The ENDURE Study
Mar 10, 2025, 14:00 PM -
Comparison of an Innovative Static Model With Dynamic Adjustment With a Dynamic Model To Assess the Public Health Impact of TAK-003 Vaccination: Case Studies in Thailand and Brazil
Mar 10, 2025, 14:00 PM -
Characteristics of Patients With Bullous Pemphigoid in the US Medicare Population
Mar 10, 2025, 14:00 PM -
Burden of Administration: Belamaf Based Combinations (BVd, BPd) Versus Carfilzomib Based Combinations (IsaKd, DKd, Kd)
Mar 10, 2025, 14:00 PM -
Interventions To Overcome the Challenges for Identifying Substandard, Spurious, Falsely Labeled, Falsified and Counterfeit Drugs (SSFFC).A Systematic Review.
Mar 10, 2025, 14:00 PM -
What Drug Characteristics Explain the Wide range of Manufacturer Rebates?
Mar 10, 2025, 14:00 PM -
An Economic Model Exploring the Impact of Formulary Restrictions on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants in the United States
Mar 10, 2025, 14:00 PM -
Cost-Utility analysis of Dinutuximab Beta in Treating High-Risk Neuroblastoma: A Partitioned Survival Model Using R programming Language
Mar 10, 2025, 14:00 PM -
Conceptual Framework for a De Novo Cost-effectiveness Model in Glycogen Storage Disease Type Ia (GSDIa)
Mar 10, 2025, 14:00 PM
